The Government of India has announced a minimum import price (MIP) for penicillin, a widely used antibiotic, aiming to stabilize the domestic market and protect local pharmaceutical manufacturers from cheap imports.
Under the new regulation, any penicillin imported into India must meet the floor price set by the Directorate General of Foreign Trade (DGFT). The move is expected to curb under priced imports, which have put pressure on Indian producers and contributed to market volatility in recent months.
Protecting Domestic Industry
Officials said the measure is intended to support domestic pharmaceutical companies, particularly small and medium-sized producers, ensuring fair competition and a sustainable pricing environment. Penicillin is a critical ingredient for various antibiotics used in hospitals , clinics, and livestock, making price stability a public health priority.
Industry experts welcomed the announcement, noting that cheap imports from some countries have eroded margins, threatening domestic production and creating supply risks. The MIP is designed to ensure local manufacturers remain competitive while meeting domestic demand.
Implementation and Oversight
The DGFT will enforce the minimum import price through customs, and imported consignments below the set price will not be cleared. The government has also indicated that periodic reviews will be conducted to adjust the MIP in line with global market trends, raw material costs, and domestic production levels.
Market Impact
Analysts expect the policy to stabilize penicillin prices in the coming months, secure production lines for local manufacturers, and reduce dependence on low-cost imports that undercut domestic players. Pharmaceutical distributors said they anticipate smoother supply chains and predictable pricing, benefiting hospitals and patients alike.
The move reflects the government’s broader strategy to strengthen India’s pharmaceutical self-reliance, safeguard critical drug supplies, and support the country’s position as a major global supplier of essential medicines.